Trial Condition(s):

Acne vulgaris, Contraception

DC 00066,Phase I Bioavailability, Bioequivalence Study

Bayer Identifier:

13854

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2008-004963-20

EU CT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below

Inclusion Criteria

No Inclusion Criteria Available

Exclusion Criteria

No Exclusion Criteria Available

Trial Summary

Enrollment Goal

Trial Dates

November2008

December2008

Phase

Could I receive a placebo?

Products

Valette (Dienogest/EE30, BAY86-5038)

Accepts Healthy Volunteers

N/A

Where to Participate

Locations

Locations
Locations SocraTec R&D Clinical Ward Erfurt, Germany, 99084	Contact Us: E-mail: [email protected] Phone: Not Available

SocraTec R&D Clinical Ward

Erfurt, Germany, 99084

Contact Us:

E-mail: [email protected]

Phone: Not Available

Acne vulgaris, Contraception

Bayer Identifier:

ClinicalTrials.gov Identifier:

EudraCT Number:

EU CT Number:

Trial Purpose

Key Participation Requirements

sex

age

55 Years

75 Years

Inclusion Criteria

Exclusion Criteria

Inclusion Criteria

Exclusion Criteria

Trial Summary

Enrollment Goal

Trial Dates

Phase

Could I receive a placebo?

Products

Accepts Healthy Volunteers

Where to Participate

For details, please refer to trial results

Additional Information